Implications of Heterogeneity in Multiple Myeloma

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Gene</td><td align="center">Frequency (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">KRAS</td><td align="center">23</td></tr><tr><td align="left">NRAS</td><td align="center">20</td></tr><tr><td align="left">DIS3</td><td align="center">11</td></tr><tr><td align="left">FAM46C</td><td align="center">11</td></tr><tr><td align="left">TP53</td><td align="center">8</td></tr><tr><td align="left">BRAF</td><td align="center">6</td></tr><tr><td align="left">TRAF3</td><td align="center">5</td></tr><tr><td align="left">PRDM1</td><td align="center">5</td></tr><tr><td align="left">RB1</td><td align="center">3</td></tr><tr><td align="left">CYLD</td><td align="center">2</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Genes affected by recurrent mutations in multiple myeloma.

BioMed Research International

tab2

Table 2

Table 2: Implications of Heterogeneity in Multiple Myeloma 